Sherbrooke Park Advisers »

Peregrine Pharmaceuticals shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $211k 19k 11.38
2023-12-31 $115k 18k 6.50

More positions owned by Sherbrooke Park Advisers

Gap (GAP)
Smartsheet Com Cl A (SMAR)
Lennar Corp Cl A (LEN)
Pure Storage Cl A (PSTG)
Micron Technology (MU)
Campbell Soup Company (CPB)
Ida (IDA)
AeroVironment (AVAV)
Pagerduty (PD)
Devon Energy Corporation (DVN)
Korn Ferry Com New (KFY)
Cardinal Health (CAH)
ConAgra Foods (CAG)
Amazon (AMZN)
Cirrus Logic (CRUS)

View all positions for Sherbrooke Park Advisers

Top funds holding Peregrine Pharmaceuticals

BlackRock
BlackRock
Point72 Asset Management
Vanguard Group
AltraVue Capital
State Street Corporation
Royal Bank of Canada
First Light Asset Management
Palisade Capital Management
Snyder Capital Management
Portolan Capital Management
Geode Capital Management
Emerald Advisers
Citadel Advisors
Harbor Capital Advisors

View all funds holding Peregrine Pharmaceuticals